Release profiles in drug-eluting stents: Issues and uncertainties
Authors:
- Subbu VenkatramanSVSubbu Venkatraman
- Freddy BoeyFBFreddy Boey
- 1 July 2007
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 120 (3) , 149-160
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Late complications following the deployment of drug eluting stentsInternational Journal of Cardiology, 2006
- Inhibition of Neointima Formation by a Novel Drug-Eluting Stent System That Allows for Dose-Adjustable, Multiple, and On-Site Stent CoatingArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Therapy Considerations in Drug-Eluting StentsCritical Reviews™ in Therapeutic Drug Carrier Systems, 2005
- Vascular Healing 4 Years After the Implantation of Sirolimus-Eluting Stent in HumansCirculation, 2004
- A Chicken in Every Pot and a Drug-Eluting Stent in Every LesionCirculation, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- New Frontiers in CardiologyCirculation, 2003
- Skin adhesives and skin adhesionBiomaterials, 1998
- Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteriesAtherosclerosis, 1995
- Polymeric stenting in the porcine coronary artery model: Differential outcome of exogenous fibrin sleeves versus polyurethane-coated stentsJACC, 1994